Tazarotene

Drug Profile

Tazarotene

Alternative Names: DFD03

Latest Information Update: 28 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dr Reddys Laboratories
  • Class Antiacnes; Antipsoriatics; Esters; Keratolytics; Nicotinic-acids; Pyrans; Pyridines; Retinoids; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Acne vulgaris

Most Recent Events

  • 31 Jul 2017 Phase-III clinical trials in Acne vulgaris (In children, In adolescents, In adults, In the elderly) in USA (Topical) (NCT03290027)
  • 06 Jul 2017 Dr. Reddy's initiates enrolment in a phase III trial for Acne vulgaris (In children, In adolescents, In adults, In the elderly) in USA (NCT03290027)
  • 21 Nov 2016 Dr.Reddy's completed a phase II trial in Acne vulgaris in Germany (Topical) (EudraCT2015-004765-90)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top